IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v9y2018i1d10.1038_s41467-018-03565-6.html
   My bibliography  Save this article

HIV envelope V3 region mimic embodies key features of a broadly neutralizing antibody lineage epitope

Author

Listed:
  • Daniela Fera

    (Harvard Medical School)

  • Matthew S. Lee

    (Harvard Medical School)

  • Kevin Wiehe

    (Duke University Medical Center
    Duke Human Vaccine Institute)

  • R. Ryan Meyerhoff

    (Duke Human Vaccine Institute
    Duke University Medical Center)

  • Alessandro Piai

    (Harvard Medical School)

  • Mattia Bonsignori

    (Duke University Medical Center
    Duke Human Vaccine Institute)

  • Baptiste Aussedat

    (Sloan Kettering Institute)

  • William E. Walkowicz

    (Sloan Kettering Institute)

  • Therese Ton

    (Swarthmore College)

  • Jeffrey O. Zhou

    (Swarthmore College)

  • Samuel Danishefsky

    (Sloan Kettering Institute)

  • Barton F. Haynes

    (Duke University Medical Center
    Duke Human Vaccine Institute)

  • Stephen C. Harrison

    (Harvard Medical School
    Harvard Medical School)

Abstract

HIV-1 envelope (Env) mimetics are candidate components of prophylactic vaccines and potential therapeutics. Here we use a synthetic V3-glycopeptide (“Man9-V3”) for structural studies of an HIV Env third variable loop (V3)-glycan directed, broadly neutralizing antibody (bnAb) lineage (“DH270”), to visualize the epitope on Env and to study how affinity maturation of the lineage proceeded. Unlike many previous V3 mimetics, Man9-V3 encompasses two key features of the V3 region recognized by V3-glycan bnAbs—the conserved GDIR motif and the N332 glycan. In our structure of an antibody fragment of a lineage member, DH270.6, in complex with the V3 glycopeptide, the conformation of the antibody-bound glycopeptide conforms closely to that of the corresponding segment in an intact HIV-1 Env trimer. An additional structure identifies roles for two critical mutations in the development of breadth. The results suggest a strategy for use of a V3 glycopeptide as a vaccine immunogen.

Suggested Citation

  • Daniela Fera & Matthew S. Lee & Kevin Wiehe & R. Ryan Meyerhoff & Alessandro Piai & Mattia Bonsignori & Baptiste Aussedat & William E. Walkowicz & Therese Ton & Jeffrey O. Zhou & Samuel Danishefsky & , 2018. "HIV envelope V3 region mimic embodies key features of a broadly neutralizing antibody lineage epitope," Nature Communications, Nature, vol. 9(1), pages 1-11, December.
  • Handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-03565-6
    DOI: 10.1038/s41467-018-03565-6
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-018-03565-6
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-018-03565-6?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Rory Henderson & Kara Anasti & Kartik Manne & Victoria Stalls & Carrie Saunders & Yishak Bililign & Ashliegh Williams & Pimthada Bubphamala & Maya Montani & Sangita Kachhap & Jingjing Li & Chuancang J, 2024. "Engineering immunogens that select for specific mutations in HIV broadly neutralizing antibodies," Nature Communications, Nature, vol. 15(1), pages 1-20, December.
    2. Rory Henderson & Ye Zhou & Victoria Stalls & Kevin Wiehe & Kevin O. Saunders & Kshitij Wagh & Kara Anasti & Maggie Barr & Robert Parks & S. Munir Alam & Bette Korber & Barton F. Haynes & Alberto Barte, 2023. "Structural basis for breadth development in the HIV-1 V3-glycan targeting DH270 antibody clonal lineage," Nature Communications, Nature, vol. 14(1), pages 1-17, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-03565-6. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.